ODS Nutrient Biomarkers Analytical Methodology: Vitamin D Workshop; Notice, 51869-51870 [E9-24334]

Download as PDF Federal Register / Vol. 74, No. 194 / Thursday, October 8, 2009 / Notices contacting Dr. Ruth Lunn (see FOR FURTHER INFORMATION CONTACT above). NTP will send registrants instructions to access the meeting remotely on or before October 30, 2009. Web conferencing is a new remote access option for RoC meetings. NTP will make every effort to ensure the best possible technical quality for these remote access options, but the audio and video quality cannot be guaranteed. Attendees registered for remote access are invited to present oral comments. The formal public comment period is scheduled for November 2, 2009. Oral public comments should not exceed 7 minutes in length and each organization is allowed only one comment slot (in person or by remote access). Every effort will be made to accommodate the public, but the total time allotted for oral comments and the time allotted per speaker by remote access will depend on the number of people who register online to speak. Remote speakers who wish to use slides with their oral comments, must send an electronic file to Dr. Lunn by October 28, 2009, for the slides to be available for Web conferencing. In addition, speakers may send a copy of their oral statement or talking points, which can supplement and/or expand the oral presentation, for distribution at the meeting and for the meeting record. Updated Draft Agenda mstockstill on DSKH9S0YB1PROD with NOTICES The updated draft agenda includes a scientific presentation on formaldehyde and leukemia requested by the NTP. Following this presentation, there will be opportunity for public comments on this topic. Pre-registration is not required to comment on this topic, and there is a 3-minute limit for each speaker. Details about the meeting, including the updated draft agenda, are available at https://ntp.niehs.nih.gov/go/29679 or by contacting Dr. Lunn (see FOR FURTHER INFORMATION CONTACT above). Updates to the meeting will be posted on this Web site. Dated: October 1, 2009. John R. Bucher, Associate Director, National Toxicology Program. [FR Doc. E9–24345 Filed 10–7–09; 8:45 am] BILLING CODE 4140–01–P VerDate Nov<24>2008 18:31 Oct 07, 2009 Jkt 220001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Council of Councils. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Council of Councils. Date: November 16–17, 2009. Time: 9 a.m. to 12 p.m. Agenda: Among the topics proposed for discussion are: updates on the Common Fund, American Recovery and Reinvestment Act, and NIH Roadmap initiatives; role of the Council. Place: National Institutes of Health, Building 31C, 31 Center Drive, Conference Room 6, Bethesda, MD 20892. Contact Person: Robin Kawazoe, Executive Secretary, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, NIH, Building 1, Room 260B, Bethesda, MD 20892, kawazoer@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuffles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 51869 Dated: September 29, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–24279 Filed 10–7–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Health and Nutrition Examination Survey (NHANES) DNA Samples: Guidelines for Proposals To Use Samples and Cost Schedule [Correction] The notice ‘‘National Health and Nutrition Examination Survey (NHANES) DNA Samples: Guidelines for Proposals to Use Samples and Cost Schedule,’’ was published in the Federal Register on September 3rd, 2009, (Vol. 74 FR No. 170). This notice is corrected as follows: On page 45647 first column, under Public Availability of Data, the Web site should read: https://www.cdc.gov/nchs/ nhanes/genetics/genetic_types.htm. Proposals for secondary data analyses linking NHANES public use data with genetic variation data will be reviewed by the Research Data Center see: https://www.cdc.gov/nchs/r&d/rdc.htm for proposal guidelines. Dated: October 1, 2009. James Stephens, Associate Director for Science, Centers for Disease Control and Prevention. [FR Doc. E9–24297 Filed 10–7–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health ODS Nutrient Biomarkers Analytical Methodology: Vitamin D Workshop; Notice Notice is hereby given of the National Institutes of Health (NIH) Office of Dietary Supplements (ODS) Nutrient Biomarkers Analytical Methodology: Vitamin D Workshop to be held Wednesday, December 16, 2009 at the Bethesda North Marriott Hotel & Conference Center in Bethesda, Maryland 20852. Summary: Vitamin D is a fat-soluble vitamin that is naturally present in very few foods, added to others, and available as a dietary supplement. It is also produced endogenously when ultraviolet rays from sunlight strike the E:\FR\FM\08OCN1.SGM 08OCN1 mstockstill on DSKH9S0YB1PROD with NOTICES 51870 Federal Register / Vol. 74, No. 194 / Thursday, October 8, 2009 / Notices skin and trigger vitamin D synthesis. Vitamin D obtained from sun exposure, food, and supplements is biologically inert and must undergo two hydroxylations in the body for activation. The first occurs in the liver and converts vitamin D to 25hydroxyvitamin D [25(OH)D], also known as calcidiol. The second occurs primarily in the kidney and forms the physiologically active 1,25dihydroxyvitamin D [1,25(OH)2D], also known as calcitriol. Serum concentration of 25(OH)D is the best indicator of exposure to vitamin D from all sources. It reflects vitamin D produced cutaneously and that obtained from food and supplements. There is considerable discussion of the serum concentrations of 25(OH)D associated with deficiency (e.g., rickets), adequacy for bone health, and optimal overall health. In fact, different assay methods are used to assess 25(OH)D. The methods themselves vary and there are considerable differences among laboratory results even when they use the same method. Given the uncertainties in vitamin D measurement, the NIH/ODS will host this one-day workshop to evaluate the state of analytical methods. The intent of the Nutrient Biomarkers Analytical Methodology: Vitamin D Workshop is to develop strategies for resolving inconsistencies between results obtained following quantitative determination of selected nutrients in biological materials such as serum when different measurement techniques are used. The desired outcomes of this meeting are to identify strengths and weaknesses of analytical approaches available for the quantification of the nutritional biomarker of Vitamin D status, circulating 25(OH)D in biological samples and to discuss analytical methods, including criteria for selection of method(s); role of reference methods and samples; sample preparation and interpretation of results. The workshop will consist of a series of short, focused podium presentations interspersed with open discussion sessions on the currently available analytical methods and interpretation of findings. A final session will summarize the discussions, identify knowledge gaps, and suggest a research agenda for future studies. The sponsor of this meeting is the NIH Office of Dietary Supplements. Registration Space is limited and will be filled on a first-come first-served basis. There is no registration fee to attend the workshop. To register please forward your name and complete mailing VerDate Nov<24>2008 18:31 Oct 07, 2009 Jkt 220001 address including phone number via email to Ms. Tricia Wallich at twallich@csionweb.com. Ms. Wallich will be coordinating the registration for this meeting. If you wish to make an oral presentation during the meeting, you must indicate this when you register and submit the following information: (1) A brief written statement of the general nature of the comments that you wish to present, (2) the name and address of the person(s) who will give the presentation, and (3) the approximate length of time that you are requesting for your presentation. Depending on the number of people who register to make presentations, we may have to limit the time allotted for each presentation. If you don’t have access to e-mail please call Ms. Wallich at 301–670–0270. Dated: October 2, 2009. Paul M. Coates, Director, Office of Dietary Supplements, National Institutes of Health. [FR Doc. E9–24334 Filed 10–7–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Agency Information Collection Activities: Customs Declaration (Form 6059B) AGENCY: U.S. Customs and Border Protection (CBP), Department of Homeland Security. ACTION: 60-Day Notice and request for comments; Revision of an existing collection of information: 1651–0009. SUMMARY: As part of its continuing effort to reduce paperwork and respondent burden, CBP invites the general public and other Federal agencies to comment on an information collection requirement concerning the Customs Declaration. This request for comment is being made pursuant to the Paperwork Reduction Act of 1995 (Pub. L. 104–13; 44 U.S.C. 3505(c)(2)). DATES: Written comments should be received on or before December 7, 2009, to be assured of consideration. ADDRESSES: Direct all written comments to U.S. Customs and Border Protection, Attn: Tracey Denning, Office of Regulations and Rulings, 799 9th Street, NW., 7th Floor, Washington, DC 20229– 1177. FOR FURTHER INFORMATION CONTACT: Requests for additional information should be directed to Tracey Denning, U.S. Customs and Border Protection, PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 Office of Regulations and Rulings, 799 9th Street, NW., 7th Floor, Washington, DC. 20229–1177, at 202–325–0265. SUPPLEMENTARY INFORMATION: CBP invites the general public and other Federal agencies to comment on proposed and/or continuing information collections pursuant to the Paperwork Reduction Act of 1995 (Pub. L. 104–13; 44 U.S.C. 3505(c)(2)). The comments should address: (a) Whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimates of the burden of the collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden including the use of automated collection techniques or the use of other forms of information technology; and (e) the annual costs burden to respondents or record keepers from the collection of information (a total capital/startup costs and operations and maintenance costs). The comments that are submitted will be summarized and included in the CBP request for Office of Management and Budget (OMB) approval. All comments will become a matter of public record. In this document CBP is soliciting comments concerning the following information collection: Title: Customs Declaration. OMB Number: 1651–0009. Form Number: CBP Form 6059B. Abstract: The Customs Declaration, CBP Form 6059B, requires basic information to facilitate the clearance of persons and goods arriving in the United States and helps CBP officers determine if any duties or taxes are due. The form is also used for the enforcement of CBP and other agencies laws and regulations. CBP proposes to increase the burden hours for this collection as a result of better estimates regarding the number of respondents filling out the Form 6059B. Specifically, CBP is revising the number of respondents to this information collection from 60,000,000 to 105,606,000. This increase in the number of respondents also results in an increase to the burden hours. In addition, CBP proposes to make a minor change to the estimated time per response by decreasing the time from 4 minutes and 5 seconds to 4 minutes. No changes were made to the Form. Current Actions: This submission is being made to extend the expiration date with a change to the burden hours. Type of Review: Extension (with change). E:\FR\FM\08OCN1.SGM 08OCN1

Agencies

[Federal Register Volume 74, Number 194 (Thursday, October 8, 2009)]
[Notices]
[Pages 51869-51870]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-24334]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


ODS Nutrient Biomarkers Analytical Methodology: Vitamin D 
Workshop; Notice

    Notice is hereby given of the National Institutes of Health (NIH) 
Office of Dietary Supplements (ODS) Nutrient Biomarkers Analytical 
Methodology: Vitamin D Workshop to be held Wednesday, December 16, 2009 
at the Bethesda North Marriott Hotel & Conference Center in Bethesda, 
Maryland 20852.
    Summary: Vitamin D is a fat-soluble vitamin that is naturally 
present in very few foods, added to others, and available as a dietary 
supplement. It is also produced endogenously when ultraviolet rays from 
sunlight strike the

[[Page 51870]]

skin and trigger vitamin D synthesis. Vitamin D obtained from sun 
exposure, food, and supplements is biologically inert and must undergo 
two hydroxylations in the body for activation. The first occurs in the 
liver and converts vitamin D to 25-hydroxyvitamin D [25(OH)D], also 
known as calcidiol. The second occurs primarily in the kidney and forms 
the physiologically active 1,25-dihydroxyvitamin D 
[1,25(OH)2D], also known as calcitriol.
    Serum concentration of 25(OH)D is the best indicator of exposure to 
vitamin D from all sources. It reflects vitamin D produced cutaneously 
and that obtained from food and supplements. There is considerable 
discussion of the serum concentrations of 25(OH)D associated with 
deficiency (e.g., rickets), adequacy for bone health, and optimal 
overall health. In fact, different assay methods are used to assess 
25(OH)D. The methods themselves vary and there are considerable 
differences among laboratory results even when they use the same 
method.
    Given the uncertainties in vitamin D measurement, the NIH/ODS will 
host this one-day workshop to evaluate the state of analytical methods. 
The intent of the Nutrient Biomarkers Analytical Methodology: Vitamin D 
Workshop is to develop strategies for resolving inconsistencies between 
results obtained following quantitative determination of selected 
nutrients in biological materials such as serum when different 
measurement techniques are used. The desired outcomes of this meeting 
are to identify strengths and weaknesses of analytical approaches 
available for the quantification of the nutritional biomarker of 
Vitamin D status, circulating 25(OH)D in biological samples and to 
discuss analytical methods, including criteria for selection of 
method(s); role of reference methods and samples; sample preparation 
and interpretation of results.
    The workshop will consist of a series of short, focused podium 
presentations interspersed with open discussion sessions on the 
currently available analytical methods and interpretation of findings. 
A final session will summarize the discussions, identify knowledge 
gaps, and suggest a research agenda for future studies.
    The sponsor of this meeting is the NIH Office of Dietary 
Supplements.

Registration

    Space is limited and will be filled on a first-come first-served 
basis. There is no registration fee to attend the workshop. To register 
please forward your name and complete mailing address including phone 
number via e-mail to Ms. Tricia Wallich at twallich@csionweb.com. Ms. 
Wallich will be coordinating the registration for this meeting. If you 
wish to make an oral presentation during the meeting, you must indicate 
this when you register and submit the following information: (1) A 
brief written statement of the general nature of the comments that you 
wish to present, (2) the name and address of the person(s) who will 
give the presentation, and (3) the approximate length of time that you 
are requesting for your presentation. Depending on the number of people 
who register to make presentations, we may have to limit the time 
allotted for each presentation. If you don't have access to e-mail 
please call Ms. Wallich at 301-670-0270.

    Dated: October 2, 2009.
Paul M. Coates,
Director, Office of Dietary Supplements, National Institutes of Health.
[FR Doc. E9-24334 Filed 10-7-09; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.